Ian Wilkinson

777 total citations
20 papers, 598 citations indexed

About

Ian Wilkinson is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ian Wilkinson has authored 20 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ian Wilkinson's work include Growth Hormone and Insulin-like Growth Factors (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Phosphodiesterase function and regulation (3 papers). Ian Wilkinson is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Phosphodiesterase function and regulation (3 papers). Ian Wilkinson collaborates with scholars based in United Kingdom, Germany and Canada. Ian Wilkinson's co-authors include Miles D. Houslay, Ralf Hoffmann, Peter Engels, J. Fraser McCALLUM, Suat Erdoğan, Grant Scotland, Richard Ross, Cathy A. Farrell, Eleanor Jones and Kate Loughney and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ian Wilkinson

20 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Wilkinson United Kingdom 12 385 148 128 70 65 20 598
Carol D. Manning United States 11 420 1.1× 89 0.6× 29 0.2× 194 2.8× 34 0.5× 18 657
Laurent Bermont France 11 207 0.5× 42 0.3× 78 0.6× 26 0.4× 17 0.3× 23 398
Luc Lévesque Canada 15 194 0.5× 46 0.3× 30 0.2× 168 2.4× 20 0.3× 22 520
Lee Chao United States 11 178 0.5× 69 0.5× 64 0.5× 63 0.9× 8 0.1× 16 490
Roland Blanqué Belgium 13 308 0.8× 51 0.3× 36 0.3× 80 1.1× 20 0.3× 31 559
E. McDermott Ireland 10 233 0.6× 28 0.2× 26 0.2× 44 0.6× 23 0.4× 15 438
Máximo Croci Argentina 15 292 0.8× 20 0.1× 25 0.2× 238 3.4× 51 0.8× 30 591
Helena Sterle Argentina 14 169 0.4× 16 0.1× 103 0.8× 107 1.5× 17 0.3× 23 413
Argyris Dritselis United States 6 151 0.4× 32 0.2× 100 0.8× 36 0.5× 33 0.5× 8 386
Nadine S. Tare United States 10 127 0.3× 31 0.2× 21 0.2× 140 2.0× 33 0.5× 17 415

Countries citing papers authored by Ian Wilkinson

Since Specialization
Citations

This map shows the geographic impact of Ian Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Wilkinson more than expected).

Fields of papers citing papers by Ian Wilkinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Wilkinson. The network helps show where Ian Wilkinson may publish in the future.

Co-authorship network of co-authors of Ian Wilkinson

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Wilkinson. A scholar is included among the top collaborators of Ian Wilkinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Wilkinson. Ian Wilkinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zarkesh‐Esfahani, Sayyed Hamid, Richard Eastell, John Newell‐Price, et al.. (2021). Development of a Hypoparathyroid Male Rodent Model for Testing Delayed-Clearance PTH Molecules. Endocrinology. 163(2). 1 indexed citations
2.
Wilkinson, Ian, et al.. (2016). A long-acting GH receptor antagonist through fusion to GH binding protein. Scientific Reports. 6(1). 35072–35072. 10 indexed citations
3.
Bielohuby, Maximilian, Sayyed Hamid Zarkesh‐Esfahani, Jenny Manolopoulou, et al.. (2014). Validation of serum IGF-I as a biomarker to monitor exogenous growth hormone agonist and antagonist bioactivity in rabbits. Disease Models & Mechanisms. 7(11). 1263–73. 14 indexed citations
4.
Wilkinson, Ian, et al.. (2013). Developing long‐acting growth hormone formulations. Clinical Endocrinology. 79(3). 305–309. 22 indexed citations
5.
Guesdon, François, Ian Wilkinson, Colin Gray, et al.. (2012). Expression of a glycosylphosphatidylinositol-anchored ligand, growth hormone, blocks receptor signalling. Bioscience Reports. 32(6). 653–660. 2 indexed citations
6.
Ferrandis, Eric, Caroline Touvay, Ian Wilkinson, et al.. (2010). Immunogenicity, toxicology, pharmacokinetics and pharmacodynamics of growth hormone ligand–receptor fusions. Clinical Science. 119(11). 483–491. 9 indexed citations
7.
Wilkinson, Ian, Eric Ferrandis, Peter J. Artymiuk, et al.. (2007). A ligand-receptor fusion of growth hormone forms a dimer and is a potent long-acting agonist. Nature Medicine. 13(9). 1108–1113. 26 indexed citations
8.
Wilkinson, Ian, et al.. (2007). A history of state aid to non-government schools in Australia : A project funded by the Department of Education, Science and Training. Queensland's institutional digital repository (The University of Queensland). 8 indexed citations
9.
Wilkinson, Ian, et al.. (2007). A History of State Aid to Non-government Schools in Australia. 22 indexed citations
10.
Wilkinson, Ian, et al.. (2006). Membrane Reinsertion of a Myristoyl-Peptidyl Anchored Extracellular Domain Growth Hormone Receptor. Endocrinology. 148(2). 824–830. 5 indexed citations
11.
Metherell, Louise, Mabrouka Maamra, María José Barahona, et al.. (2004). Growth Hormone (GH) Insensitivity Syndrome due to a GH Receptor Truncated after Box1, Resulting in Isolated Failure of STAT 5 Signal Transduction. The Journal of Clinical Endocrinology & Metabolism. 89(3). 1259–1266. 48 indexed citations
12.
Wilkinson, Ian, et al.. (2002). Pegvisomant: structure and function. Journal of Molecular Endocrinology. 29(1). 11–14. 53 indexed citations
13.
Higginbottom, Adrian, Ian Wilkinson, François Lanza, et al.. (2000). Antibody cross‐linking of human CD9 and the high‐affinity immunoglobulin E receptor stimulates secretion from transfected rat basophilic leukaemia cells. Immunology. 99(4). 546–552. 13 indexed citations
14.
Hoffmann, Ralf, Ian Wilkinson, J. Fraser McCALLUM, Peter Engels, & Miles D. Houslay. (1998). cAMP-specific phosphodiesterase HSPDE4D3 mutants which mimic activation and changes in rolipram inhibition triggered by protein kinase A phosphorylation of Ser-54: generation of a molecular model. Biochemical Journal. 333(1). 139–149. 135 indexed citations
15.
Erdoğan, Suat, Eleanor Jones, Kate Loughney, et al.. (1997). Characterization of five different proteins produced by alternatively spliced mRNAs from the human cAMP-specific phosphodiesterase PDE4D gene. Biochemical Journal. 328(2). 539–548. 162 indexed citations
16.
Thompson, Robert G., et al.. (1996). CONGENITAL ADRENAL HYPERPLASIA (CAH) NEWBORN SCREENING IN MANITOBA 1989-1994. 564. Pediatric Research. 39. 96–96. 1 indexed citations
17.
18.
Goward, Christopher R., et al.. (1989). Use of Macrosorb kieselguhr composite and CM-Sepharose Fast Flow for the large-scale purification of l-asparaginase from Erwinia chrysanthemi. Enzyme and Microbial Technology. 11(12). 810–814. 5 indexed citations
19.
Wilkinson, Ian, et al.. (1987). Tolerogenic polyethylene glycol derivatives of xenogeneic monoclonal immunoglobulins. Immunology Letters. 15(1). 17–22. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carol D. Manning Breakdown of academic impact, for papers by Laurent Bermont Breakdown of academic impact, for papers by Luc Lévesque Breakdown of academic impact, for papers by Lee Chao Breakdown of academic impact, for papers by Roland Blanqué Breakdown of academic impact, for papers by E. McDermott Breakdown of academic impact, for papers by Máximo Croci Breakdown of academic impact, for papers by Helena Sterle Breakdown of academic impact, for papers by Argyris Dritselis Breakdown of academic impact, for papers by Nadine S. Tare
Rankless by CCL
2026